1. Home
  2. RVSB vs NKTX Comparison

RVSB vs NKTX Comparison

Compare RVSB & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVSB
  • NKTX
  • Stock Information
  • Founded
  • RVSB 1923
  • NKTX 2015
  • Country
  • RVSB United States
  • NKTX United States
  • Employees
  • RVSB N/A
  • NKTX N/A
  • Industry
  • RVSB Savings Institutions
  • NKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • RVSB Finance
  • NKTX Health Care
  • Exchange
  • RVSB Nasdaq
  • NKTX Nasdaq
  • Market Cap
  • RVSB 107.6M
  • NKTX 123.5M
  • IPO Year
  • RVSB 1993
  • NKTX 2020
  • Fundamental
  • Price
  • RVSB $4.86
  • NKTX $1.95
  • Analyst Decision
  • RVSB Buy
  • NKTX Strong Buy
  • Analyst Count
  • RVSB 1
  • NKTX 5
  • Target Price
  • RVSB $7.00
  • NKTX $13.50
  • AVG Volume (30 Days)
  • RVSB 39.2K
  • NKTX 519.8K
  • Earning Date
  • RVSB 10-23-2025
  • NKTX 11-06-2025
  • Dividend Yield
  • RVSB 1.62%
  • NKTX N/A
  • EPS Growth
  • RVSB 163.90
  • NKTX N/A
  • EPS
  • RVSB 0.24
  • NKTX N/A
  • Revenue
  • RVSB $51,318,000.00
  • NKTX N/A
  • Revenue This Year
  • RVSB $11.67
  • NKTX N/A
  • Revenue Next Year
  • RVSB $12.55
  • NKTX N/A
  • P/E Ratio
  • RVSB $20.56
  • NKTX N/A
  • Revenue Growth
  • RVSB 9.48
  • NKTX N/A
  • 52 Week Low
  • RVSB $4.45
  • NKTX $1.31
  • 52 Week High
  • RVSB $6.59
  • NKTX $5.88
  • Technical
  • Relative Strength Index (RSI)
  • RVSB 42.63
  • NKTX 39.34
  • Support Level
  • RVSB $4.83
  • NKTX $2.00
  • Resistance Level
  • RVSB $5.12
  • NKTX $2.08
  • Average True Range (ATR)
  • RVSB 0.14
  • NKTX 0.10
  • MACD
  • RVSB -0.00
  • NKTX -0.03
  • Stochastic Oscillator
  • RVSB 26.67
  • NKTX 6.41

About RVSB Riverview Bancorp Inc

Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: